These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8978850)

  • 1. Synthesis and protein kinase C inhibitory activities of acyclic balanol analogs that are highly selective for protein kinase C over protein kinase A.
    Defauw JM; Murphy MM; Jagdmann GE; Hu H; Lampe JW; Hollinshead SP; Mitchell TJ; Crane HM; Heerding JM; Mendoza JS; Davis JE; Darges JW; Hubbard FR; Hall SE
    J Med Chem; 1996 Dec; 39(26):5215-27. PubMed ID: 8978850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and protein kinase C inhibitory activities of balanol analogs with replacement of the perhydroazepine moiety.
    Lai YS; Mendoza JS; Jagdmann GE; Menaldino DS; Biggers CK; Heerding JM; Wilson JW; Hall SE; Jiang JB; Janzen WP; Ballas LM
    J Med Chem; 1997 Jan; 40(2):226-35. PubMed ID: 9003521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of the potent natural product inhibitor balanol in complex with the catalytic subunit of cAMP-dependent protein kinase.
    Narayana N; Diller TC; Koide K; Bunnage ME; Nicolaou KC; Brunton LL; Xuong NH; Ten Eyck LF; Taylor SS
    Biochemistry; 1999 Feb; 38(8):2367-76. PubMed ID: 10029530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta.
    Jirousek MR; Gillig JR; Gonzalez CM; Heath WF; McDonald JH; Neel DA; Rito CJ; Singh U; Stramm LE; Melikian-Badalian A; Baevsky M; Ballas LM; Hall SE; Winneroski LL; Faul MM
    J Med Chem; 1996 Jul; 39(14):2664-71. PubMed ID: 8709095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular design and biological activity of potent and selective protein kinase inhibitors related to balanol.
    Koide K; Bunnage ME; Gomez Paloma L; Kanter JR; Taylor SS; Brunton LL; Nicolaou KC
    Chem Biol; 1995 Sep; 2(9):601-8. PubMed ID: 9383464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and protein kinase C inhibitory activities of balanol analogues with modification of 4-hydroxybenzamido moiety.
    Hu H; Mendoza JS; Lowden CT; Ballas LM; Janzen WP
    Bioorg Med Chem; 1997 Sep; 5(9):1873-82. PubMed ID: 9354244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential and selective inhibition of protein kinase A and protein kinase C in intact cells by balanol congeners.
    Gustafsson AB; Brunton LL
    Mol Pharmacol; 1999 Aug; 56(2):377-82. PubMed ID: 10419557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human glutathione S-transferase P1 protein is phosphorylated and its metabolic function enhanced by the Ser/Thr protein kinases, cAMP-dependent protein kinase and protein kinase C, in glioblastoma cells.
    Lo HW; Antoun GR; Ali-Osman F
    Cancer Res; 2004 Dec; 64(24):9131-8. PubMed ID: 15604283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of charge states of balanol analogues acting as ATP-competitive inhibitors in kinases.
    Hardianto A; Yusuf M; Liu F; Ranganathan S
    BMC Bioinformatics; 2017 Dec; 18(Suppl 16):572. PubMed ID: 29297286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rottlerin, a novel protein kinase inhibitor.
    Gschwendt M; Müller HJ; Kielbassa K; Zang R; Kittstein W; Rincke G; Marks F
    Biochem Biophys Res Commun; 1994 Feb; 199(1):93-8. PubMed ID: 8123051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balanol analogues probe specificity determinants and the conformational malleability of the cyclic 3',5'-adenosine monophosphate-dependent protein kinase catalytic subunit.
    Akamine P; Madhusudan ; Brunton LL; Ou HD; Canaves JM; Xuong NH; Taylor SS
    Biochemistry; 2004 Jan; 43(1):85-96. PubMed ID: 14705934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-preventive selenocompounds induce a specific redox modification of cysteine-rich regions in Ca(2+)-dependent isoenzymes of protein kinase C.
    Gopalakrishna R; Gundimeda U; Chen ZH
    Arch Biochem Biophys; 1997 Dec; 348(1):25-36. PubMed ID: 9390171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular docking of balanol to dynamics snapshots of protein kinase A.
    Wong CF; Kua J; Zhang Y; Straatsma TP; McCammon JA
    Proteins; 2005 Dec; 61(4):850-8. PubMed ID: 16245317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of several kinases in mice tolerant to delta 9-tetrahydrocannabinol.
    Lee MC; Smith FL; Stevens DL; Welch SP
    J Pharmacol Exp Ther; 2003 May; 305(2):593-9. PubMed ID: 12606657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potent, selective protein kinase C inhibitors based on a phorbol skeleton.
    Yamatsugu K; Motoki R; Kanai M; Shibasaki M
    Chem Asian J; 2006 Sep; 1(3):314-21. PubMed ID: 17441066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and protein kinase inhibitory activity of balanol analogues with modified benzophenone subunits.
    Lampe JW; Biggers CK; Defauw JM; Foglesong RJ; Hall SE; Heerding JM; Hollinshead SP; Hu H; Hughes PF; Jagdmann GE; Johnson MG; Lai YS; Lowden CT; Lynch MP; Mendoza JS; Murphy MM; Wilson JW; Ballas LM; Carter K; Darges JW; Davis JE; Hubbard FR; Stamper ML
    J Med Chem; 2002 Jun; 45(12):2624-43. PubMed ID: 12036372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R.
    Traxler P; Furet P; Mett H; Buchdunger E; Meyer T; Lydon N
    J Pharm Belg; 1997; 52(2):88-96. PubMed ID: 9193132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and target identification of hymenialdisine analogs.
    Wan Y; Hur W; Cho CY; Liu Y; Adrian FJ; Lozach O; Bach S; Mayer T; Fabbro D; Meijer L; Gray NS
    Chem Biol; 2004 Feb; 11(2):247-59. PubMed ID: 15123286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of protein kinase C phosphorylation sites in the angiotensin II (AT1A) receptor.
    Qian H; Pipolo L; Thomas WG
    Biochem J; 1999 Nov; 343 Pt 3(Pt 3):637-44. PubMed ID: 10527943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.